Viatris Inc

Biosimilars

Increasing access to biologics

We're committed to increasing patient access to quality, affordable medicines. One of the ways we’re working to achieve this goal is our focus on biosimilar medicines. Biosimilars can fill an urgent, unmet patient need for more affordable alternatives to existing branded biologic therapies. Biosimilar medicines are approved by regulatory authorities as highly similar to the originally approved brand version with no clinically meaningful differences in safety or efficacy.

Multiple therapeutic areas of opportunity

Biologic medicines are used to treat many types of health conditions, such as cancer and rheumatoid arthritis. Biosimilar versions are increasingly available as therapeutic alternatives for patients facing many serious diseases, including diabetes, autoimmune disorders and multiple cancers.

Diabetes and metabolism

Immunology

Oncology

An extensive portfolio of biosimilars

We offer one of the industry’s largest and most diverse global biosimilars franchises focused on the areas of oncology, immunology, endocrinology, ophthalmology and dermatology. These vital products can help increase access for current and future patients while supporting the sustainability of healthcare systems.